Fig. 1From: Angiotensin II promotes ovarian cancer spheroid formation and metastasis by upregulation of lipid desaturation and suppression of endoplasmic reticulum stressAGTR1 is upregulated in ovarian cancer tissues and negatively associated with prognosis. a AGTR1 mRNA expression profile in tissues of ovarian cancer (n = 902) and healthy controls (n = 50). The data were extracted from the GENT database. The data are presented as means ± SEM, *** p < 0.001, Student’s t-test. b AGTR1 mRNA expression patterns for four independent ovarian cancer studies (GSE12172, GSE26712, GSE12471, and TCGA ovarian carcinoma project). c Representative IHC staining images of AGTR1 from different pathological subtypes of ovarian cancer (Serous n = 30, Mucinous n = 3, Clear n = 3, Borderline n = 4, Benign n = 4), Scale bar = 50 μm. d IHC scores for different pathological types were assessed according to AGTR1 cellular location and signaling intensity. e Kaplan–Meier survival analysis based on AGTR1 expression levels in ovarian cancer patients (log-rank test). Patients with top 25% expression level of AGTR1 are defined as the AGTR1 high group and the bottom 25% patients are defined as the AGTR1 low group. Median overall survival (OS) 41.63 vs 57 months, n = 294, p = 0.0301). f-h The Kaplan–Meier survival analysis (log-rank test) based on cancer grade of the patients. The higher expression level of AGTR1 had poor outcomes in the Grade 1 (OS 18.1 vs > 120 months, n = 37, p = 0.0005) and Grade 2 (OS 19.5 vs 25.3, n = 256, p = 0.0094) patients, but was not significant for Grade 3 patients (n = 1015, p = 0.097)Back to article page